The digital pathology market is driven by increased teleconsultations, increased usage of digital pathology to improve lab efficiency, and its application in drug discovery and companion diagnostics.

Digital pathology, encompassing high-resolution scanners, software platforms, and advanced image storage systems, is revolutionizing how clinicians, researchers, and pharmaceutical organizations ...

Deciphex announced the launch of Diagnexia, the company’s remote diagnostic service, in the U.S. as workforce shortages continue to slow the speed of medical care and cripple rural healthcare. The ...

AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has acquired PathXL, a Northern Ireland-based leader in digital pathology image analysis, workflow software and ...

Roche has launched its uPath enterprise software for digital pathology, billing it as an improvement in speed and performance compared to its previous version known as Ventana Virtuoso. According to ...

TUCSON, Ariz., May 19, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announces the release of VENTANA Vector software, a new platform for pathology ...

As tissue slides are more routinely digitized to aid interpretation, a software program whose design was led by the University of Michigan Health System is proving its utility. In a new study, a ...

CRO Charles River Laboratories has signed up to use a preclinical digital pathology “software-as-a-service” platform from Deciphex. The deal, financials of which were not shared, sees Charles River ...

Proscia, a health IT startup that developed a platform for digital pathology software aimed at clinicians and researchers to make the process of sharing and storing data easier to support cancer ...